NCT06582888View on ClinicalTrials.gov

Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 19, 2024

Primary Completion Date

August 15, 2028

Study Completion Date

August 15, 2028

Conditions
Nicotine AddictionCraving
Interventions
DRUG

Varenicline Tartrate

varenicline (target dose 1mg twice daily)

DRUG

Placebo

matched placebo

Trial Locations (1)

92093

RECRUITING

University California, San Diego, San Diego

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of California, San Diego

OTHER